Our Mission and Values
Board
Leadership Team
Scientific Advisory
Corporate Governance
Intellectual Property
Pipeline
CVac™
Monoclonal Antibody
Vaccines Program
R&D
Ovarian Cancer
About CVac™
Treatment
Clinical Trials
Clinical Trials
CVac™
CAN-003
CANVAS
FAQ
Useful Links
Contact Us
Analyst Reports
Presentations
Annual Reports
Mailing List
Movie about CVac™
Investor Updates
Announcements
Announcements
Archive
Contact
Sydney Office
Ph: +61 2 9276 1224
Fax: +61 2 9276 1284
Email:
enquiries@primabiomed.com.au
Level 7,151 Macquarie Street,
SYDNEY NSW
AUSTRALIA 2000
Please send your enquiries for clinical trail to
ClinicalTrials.gov
.
Please refer to CVac™ study by its
ClinicalTrials.gov
identifier: NCT01068509.
Privacy Policy
© 2012 PRIMA BIOMED LTD. All Rights Reserved.
Home
Site Map
Contact Us
Search